Aspiriant LLC
MKC icon

Aspiriant LLC’s McCormick & Company Non-Voting MKC Stock Holding History

Aspiriant LLC’s Portfolio MKC Stock Details MKC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-4,153
Closed -$209K – 445
2026
Q2 		$209K Buy
+4,153
New +$204K 0.01% 380

Other funds holding MKC

Sanders Capital
Sanders Capital West Palm Beach, Florida $103B AUM 36.66% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
ProShare Advisors
ProShare Advisors Bethesda, Maryland $69.5B AUM 31.38% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Alecta Tjanstepension Omsesidigt
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $24.1B AUM 30.72% 1-Year Est. Return
Vest Financial
Vest Financial Mclean, Virginia $9.5B AUM 22.78% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $194B AUM 32.2% 1-Year Est. Return
DePrince Race & Zollo Inc (DRZ)
DePrince Race & Zollo Inc (DRZ) Winter Park, Florida $5.66B AUM 23.19% 1-Year Est. Return
Old Republic International (ORI)
Old Republic International (ORI) Chicago, Illinois $2.24B AUM 20.05% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return

Aspiriant LLC's MKC Position: Q3 2026 in Review

Aspiriant LLC sold out of McCormick & Company Non-Voting (MKC) in Q3 2026, closing a stake of 4,153 shares — an estimated $209K sold.

Aspiriant LLC first reported a position in MKC in Q2 2026 and held it in 1 quarter. The position peaked at $209K in Q2 2026. 466 funds tracked by Wall St. Rank hold MKC as of Q3 2026.

  • Aspiriant LLC reported no remaining McCormick & Company Non-Voting position as of Q3 2026 after selling out during the quarter.
  • Aspiriant LLC sold 4,153 McCormick & Company Non-Voting shares in Q3 2026, an estimated $209K.
  • Aspiriant LLC first reported a position in McCormick & Company Non-Voting in Q2 2026 and held it in 1 quarter.
  • Aspiriant LLC's McCormick & Company Non-Voting position peaked at $209K in Q2 2026.
  • 466 funds tracked by Wall St. Rank held McCormick & Company Non-Voting as of Q3 2026.

Based on Aspiriant LLC's 13F filing for Q3 2026, filed 16 Oct 2026.